D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
PSTX holding history
Poseida Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PSTX overviewAll 13F holders of PSTXFull Q2 2026 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −27,173−100.0% | Sold out | Holders |
| Q2 2023 | 27,173 | $47.8K | <0.1% | −58,456−68.3% | Reduced | Holders |
| Q1 2023 | 85,629 | $263.7K | <0.1% | −253,492−74.7% | Reduced | Holders |
| Q4 2022 | 339,121 | $1.80M | <0.1% | +143,237+73.1% | Added | Holders |
| Q3 2022 | 195,884 | $691.0K | <0.1% | +195,884 | New | Holders |